{4-[4-(2,4-Difluorophenoxy)-5-methyl-1H-pyrazol-3-yl]-3-hydroxyphenoxy}acetic Acid

ID: ALA5183786

Chembl Id: CHEMBL5183786

PubChem CID: 168281297

Max Phase: Preclinical

Molecular Formula: C18H14F2N2O5

Molecular Weight: 376.32

Names and Identifiers

Canonical SMILES:  Cc1[nH]nc(-c2ccc(OCC(=O)O)cc2O)c1Oc1ccc(F)cc1F

Standard InChI:  InChI=1S/C18H14F2N2O5/c1-9-18(27-15-5-2-10(19)6-13(15)20)17(22-21-9)12-4-3-11(7-14(12)23)26-8-16(24)25/h2-7,23H,8H2,1H3,(H,21,22)(H,24,25)

Standard InChI Key:  RLTICMYBBXHRMC-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5183786

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 376.32

Molecular Weight (Monoisotopic): 376.0871

AlogP: 3.62

#Rotatable Bonds: 6

Polar Surface Area: 104.67

Molecular Species: ACID

HBA: 5

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 3.04

CX Basic pKa: 1.83

CX LogP: 3.02

CX LogD: -0.22

Aromatic Rings: 3

Heavy Atoms: 27

QED Weighted: 0.61

Np Likeness Score: -1.11

References

1. Khiar-Fernández N, Zian D, Vázquez-Villa H, Martínez RF, Escobar-Peña A, Foronda-Sainz R, Ray M, Puigdomenech-Poch M, Cincilla G, Sánchez-Martínez M, Kihara Y, Chun J, López-Vales R, López-Rodríguez ML, Ortega-Gutiérrez S..  (2022)  Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA₂), UCM-14216, Ameliorates Spinal Cord Injury in Mice.,  65  (16.0): [PMID:35948083] [10.1021/acs.jmedchem.2c00046]

Source

Source(1):

• Scientific Literature